4basebio PLC (4BB.L) LSE

Currency In GBp

AD

4basebio PLC

Address

25 Norman Way

Cambridge, CB24 5QE

United Kingdom of Great Britain and Northern Ireland (the)

Phone

44 1223 967 943

Sector

Healthcare

Industry

Biotechnology

Employees

101

First IPO Date

February 17, 2021

Key Executives

NameTitlePayYear Born
Amy WalkerCEO & Director339,0001993
Manja Hermina Elisabeth Maria BoermanExecutive Chair of the Board63,4001966
Scott LorimerChief Operating Officer0N/A
Christine WolosinChief Commercial Officer0N/A
Jennifer GelmanVice President of Marketing0N/A
AD

Description

4basebio PLC, an enterprise established in 2020 and situated in Cambridge, United Kingdom, is dedicated to the entire process, from conception to delivery, of synthetic DNA and RNA products. The company also provides advanced non-viral vector solutions, with operations spanning the United States, Europe, and other international markets. Their comprehensive offerings encompass research kits, bulk enzymes, various other biological products, as well as crucial licensing and AVV manufacturing services. The company primarily caters to clients within the biotech, pharmaceutical, and contract development and manufacturing organization (CDMO) industries. Notably, the firm adopted its current name, 4basebio PLC, in July 2021, having previously been known as 4basebio UK Societas.

AD